Amanote Research
Register
Sign In
Chemotherapeutic Agent for Glioma
doi 10.5772/54353
Full Text
Open PDF
Abstract
Available in
full text
Date
April 10, 2013
Authors
Shinji Kohsaka
Shinya Tanak
Publisher
InTech
Related search
2,3-Diphenyl-1,4-Naphthoquinone: A Potential Chemotherapeutic Agent Against Trypanosoma Cruzi
Journal of Parasitology
Evolution
Ecology
Systematics
Parasitology
Behavior
Medicine
Optimizing a Novel Regional Chemotherapeutic Agent Against Melanoma: Hyperthermia-Induced Enhancement of Temozolomide Cytotoxicity
Clinical Cancer Research
Cancer Research
Oncology
Prolonged Deleterious Influences of Chemotherapeutic Agent CPT-11 on Resident Peritoneal Macrophages and B1 Cells
Frontiers in Immunology
Allergy
Immunology
Water-Soluble L-Cysteine-Coated FePt Nanoparticles as Dual MRI/CT Imaging Contrast Agent for Glioma
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Chemotherapeutic Products
BMJ
Radiotherapy for Low-Grade Glioma(Probably Benign-Glioma)
Japanese Journal of Neurosurgery
Surgery
Neurology
Multiphysics and Multiscale Analysis for Chemotherapeutic Drug
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Incorporation of Drug Efflux Inhibitor and Chemotherapeutic Agent Into an Inorganic/Organic Platform for the Effective Treatment of Multidrug Resistant Breast Cancer
Journal of Nanobiotechnology
Applied Microbiology
Molecular Medicine
Nanoscience
Pharmaceutical Science
Medicine
Biotechnology
Bioengineering
Biomedical Engineering
Nanotechnology
Evaluation of Uttroside B, a Saponin From Solanum Nigrum Linn, as a Promising Chemotherapeutic Agent Against Hepatocellular Carcinoma
Scientific Reports
Multidisciplinary
